Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab

被引:34
|
作者
Puxeddu, Ilaria [1 ]
Giori, Lucia [1 ]
Rocchi, Valeria [1 ]
Bazzichi, Laura [2 ]
Bombardieri, Stefano [2 ]
Tavoni, Antonio [1 ]
Migliorini, Paola [1 ]
Del Corso, Isabella [1 ]
机构
[1] Univ Pisa, Dept Internal Med, Clin Immunol Unit, Pisa, Italy
[2] Univ Pisa, Dept Internal Med, Rheumatol Unit, Pisa, Italy
关键词
ANTITUMOR NECROSIS FACTOR; RHEUMATOID-ARTHRITIS; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; THERAPY; TRIAL;
D O I
10.1016/j.anai.2011.11.004
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:123 / 124
页数:2
相关论文
共 50 条
  • [3] COMPARISON OF ANTERIOR UVEITIS OCCURRENCE DURING TREATMENT WITH SECUKINUMAB, ADALIMUMAB, INFLIXIMAB AND ETANERCEPT IN SPONDYLOARTHRITIS
    Lindstrom, U.
    Bengtsson, K.
    Olofsson, T.
    Di Giuseppe, D.
    Glintborg, B.
    Forsblad-D'elia, H.
    Jacobsson, L. T. H.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 9 - 10
  • [6] Relationship Between Immunogenicity, Hypersensitivity Reactions and Skin Tests Against Infliximab, Etanercept and Adalimumab in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    Doghanji, Firas
    Ataman, Sebnem
    Ozdemirel, Ali Erhan
    Seckin, Recep Bulent
    Yalcin, Ayse Peyman
    Bavbek, Sevim
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [7] Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease
    Steenholdt, Casper
    Svenson, Morten
    Bendtzen, Klaus
    Thomsen, Ole Ostergaard
    Brynskov, Jorn
    Ainsworth, Mark Andrew
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (01): : 108 - 111
  • [8] Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation
    McLeod, C.
    Bagust, A.
    Boland, A.
    Dagenais, P.
    Dickson, R.
    Dundar, Y.
    Hill, R. A.
    Jones, A.
    Mota, R. Mujica
    Walley, T.
    HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (28) : IX - +
  • [9] Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    Rodgers, M.
    Epstein, D.
    Bojke, L.
    Yang, H.
    Craig, D.
    Fonseca, T.
    Myers, L.
    Bruce, I.
    Chalmers, R.
    Bujkiewicz, S.
    Lai, M.
    Cooper, N.
    Abrams, K.
    Spiegelhalter, D.
    Sutton, A.
    Sculpher, M.
    Woolacott, N.
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (10) : 1 - +
  • [10] Switching of infliximab to either etanercept or adalimumab - The Cannock experience
    Roskell, S
    Barber, J
    Venkatachalam, S
    Mulherin, D
    Sheeran, TP
    Price, T
    RHEUMATOLOGY, 2005, 44 : I157 - I157